Trial
NCT01400672
Imiquimod/Brain Tumor Initiating Cell (BTIC) Vaccine in Brain Stem Glioma
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Masonic Cancer Center, University of Minnesota
Collaborators
—
Condition
Diffuse Intrinsic Pontine Glioma
Intervention
Tumor Lysate Vaccine
Why stopped
Treatment ineffective; Extreme toxicity
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-03-18